LN-145/LN-144
IOV-PED-101
Phase 1 mab active
Quick answer
LN-145/LN-144 for Soft Tissue Sarcoma is a Phase 1 program (mab) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Soft Tissue Sarcoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active